Equities

Zhende Medical Co Ltd

603301:SHH

Zhende Medical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)19.23
  • Today's Change-0.150 / -0.77%
  • Shares traded1.49m
  • 1 Year change-43.47%
  • Beta1.7187
Data delayed at least 15 minutes, as of Apr 18 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Zhende Medical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of medical dressing products. The Company’s main products include modern wound dressings, surgical control products, traditional wound care products and pressure treatment and fixation products. The Company mainly distributes its products in domestic market and to overseas markets.

  • Revenue in CNY (TTM)5.15bn
  • Net income in CNY526.61m
  • Incorporated1994
  • Employees8.49k
  • Location
    Zhende Medical Co LtdNo. 55 Xiangji RoadGaobu Neighborhood, Yuecheng DistrictSHAOXING 312035ChinaCHN
  • Phone+86 57 588751963
  • Fax+86 57 588751963
  • Websitehttp://www.zhende.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sino Medical Sciences Technology Inc361.15m-20.92m4.99bn652.00--6.08--13.83-0.051-0.0510.88092.000.31091.3424.46553,914.40-1.62-4.21-1.95-4.7158.1470.96-5.22-15.761.55--0.1442--77.99-2.0475.59---7.30--
Chimin Health Management Co Ltd905.45m-84.34m5.01bn1.95k--3.13--5.54-0.1933-0.19331.712.990.35144.165.08465,050.00-2.881.54-3.702.4140.3544.32-8.204.051.24-3.960.262829.556.845.09-289.97---10.57--
SWS Hemodialysis Care Co Ltd659.16m154.15m5.22bn881.0033.863.03--7.920.71480.71483.067.970.33512.115.56748,197.707.71--8.68--50.81--23.00--15.96--0.0089--80.65--228.34------
Hubei Huaqiang High-Tech Co Ltd502.24m4.95m5.46bn706.001,102.991.31--10.870.01440.01441.4612.150.09931.830.7415711,388.300.09783.820.10784.6211.7326.280.985314.297.84--0.004320.55-2.21-5.08-88.36-40.15-12.17--
Qingdao NovelBeam Technology Co Ltd439.81m135.69m5.75bn797.0042.204.31--13.071.121.123.6210.950.31381.084.50551,832.809.4514.6710.0716.6362.5462.3230.1134.1511.88--0.003933.55-1.3118.58-20.1921.7110.45--
Zhejiang Gongdong Medical Techno Co Ltd1.02bn125.32m5.95bn1.67k47.433.53--5.831.111.119.0714.980.54476.004.59609,805.406.6916.357.4619.2631.1341.1912.2821.623.85--0.020138.99-33.6115.11-66.535.1427.71--
Zhende Medical Co Ltd5.15bn526.61m6.08bn8.49k11.641.10--1.181.961.9619.2720.680.68013.347.45606,869.407.2521.449.4230.9035.2038.8110.6618.871.62171.270.111123.1320.5436.2614.3141.1039.17--
Xiangyu Medical Co Ltd770.75m227.62m6.23bn1.82k26.892.94--8.081.451.454.9013.230.29681.0818.95423,724.108.8011.1810.7913.1267.6666.7829.6432.691.89--0.124727.3352.4615.7281.0323.11132.76--
Data as of Apr 18 2024. Currency figures normalised to Zhende Medical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

8.90%Per cent of shares held by top holders
HolderShares% Held
HFT Investment Management Co., Ltd.as of 30 Jun 20233.75m1.65%
China Merchants Fund Management Co., Ltd.as of 30 Jun 20233.63m1.60%
Rongtong Fund Management Co., Ltd.as of 30 Jun 20233.05m1.34%
Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 20232.87m1.26%
Essence Fund Co., Ltd.as of 30 Jun 20232.73m1.20%
Galaxy Asset Management Co., Ltd.as of 30 Jun 20231.24m0.55%
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2023996.70k0.44%
The Vanguard Group, Inc.as of 31 Mar 2024738.99k0.33%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 2023692.05k0.31%
Bank of China Investment Management Co., Ltd.as of 30 Jun 2023508.20k0.22%
More ▼
Data from 30 Jun 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.